Li, Siwei http://orcid.org/0000-0001-6057-2957
An, Jingjing
Li, Yaqiu
Zhu, Xiagu
Zhao, Dongdong http://orcid.org/0000-0001-9691-1308
Wang, Lixian
Sun, Yonghui
Yang, Yuanzhao
Bi, Changhao http://orcid.org/0000-0002-1940-8511
Zhang, Xueli http://orcid.org/0000-0002-8660-4037
Wang, Meng http://orcid.org/0000-0001-7648-9955
Funding for this research was provided by:
National Natural Science Foundation of China (32171449, 32271483, 32001041)
National Key Laboratory of Science and Technology on Communications (2018YFA0902900)
Article History
Received: 22 April 2022
Accepted: 17 November 2022
First Online: 30 November 2022
Competing interests
: A provisional patent has been submitted in part entailing the reported approach. The patent author contains M.W., J.A., X.L.Z., C.B., S.L., Y.L., the institution is “Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China”, and the patent application number: CN202210360423.9. The status is under review. The title is a high-throughput method of construction of mammalian cell disease models, specific aspect of manuscript covered in patent application: Development of an automated platform for genome editing in mammalian cells in Results of manuscript. X.G.Z., Y.Y., D.Z., L.W., and Y.S. declare no potential conflict of interest.